| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | opsonin binding | 5.87e-06 | 25 | 96 | 4 | GO:0001846 | |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 1.26e-05 | 10 | 96 | 3 | GO:0001849 | |
| GeneOntologyMolecularFunction | complement binding | 1.63e-05 | 32 | 96 | 4 | GO:0001848 | |
| GeneOntologyMolecularFunction | ATP-dependent FeS chaperone activity | 6.84e-05 | 3 | 96 | 2 | GO:0140663 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.71e-04 | 65 | 96 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 3.98e-04 | 279 | 96 | 7 | GO:0005096 | |
| GeneOntologyMolecularFunction | GPI-linked ephrin receptor activity | 4.73e-04 | 7 | 96 | 2 | GO:0005004 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 7.54e-04 | 85 | 96 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | calcium ion binding | SPARC DSG2 ESYT1 FAT3 PCDHA10 ADGRV1 FAT2 HMCN2 CELSR3 PCDH11X ATP2B2 | 9.33e-04 | 749 | 96 | 11 | GO:0005509 |
| GeneOntologyMolecularFunction | growth factor binding | 9.42e-04 | 156 | 96 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 1.26e-03 | 439 | 96 | 8 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 1.26e-03 | 439 | 96 | 8 | GO:0019001 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 1.49e-03 | 102 | 96 | 4 | GO:0001540 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DSG2 FAT3 PCDHA10 ITGAM WNK1 MAGI2 MMP24 FAT2 HMCN2 CELSR3 PKD1 PCDH11X MDGA1 | 2.02e-09 | 313 | 95 | 13 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DSG2 FAT3 PCDHA10 TNIP1 ADGRV1 ITGAM WNK1 IGDCC4 MAGI2 MMP24 FAT2 HMCN2 CELSR3 PKD1 PCDH11X MDGA1 MEGF10 EPHA7 | 1.76e-06 | 1077 | 95 | 18 | GO:0098609 |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 2.10e-06 | 247 | 95 | 9 | GO:0009612 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 2.44e-06 | 187 | 95 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | SPARC WDR36 CHODL ACHE NTRK1 FAT3 VSIG1 LAMA5 LAMB3 CREB1 SLC1A3 ARHGDIA HMCN2 CELSR3 NBEAL2 PLEC ATP2B2 EPHA7 | 7.43e-06 | 1194 | 95 | 18 | GO:0000902 |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 2.49e-05 | 75 | 95 | 5 | GO:0050982 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | WDR36 CHODL ACHE NTRK1 FAT3 LAMA5 LAMB3 CREB1 SLC1A3 HMCN2 CELSR3 ATP2B2 EPHA7 | 3.81e-05 | 748 | 95 | 13 | GO:0048667 |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly actin filament organization | 1.25e-04 | 4 | 95 | 2 | GO:2000689 | |
| GeneOntologyBiologicalProcess | positive regulation of striated muscle tissue development | 1.25e-04 | 4 | 95 | 2 | GO:0045844 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle organ development | 1.25e-04 | 4 | 95 | 2 | GO:0048636 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 1.38e-04 | 57 | 95 | 4 | GO:0050974 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 1.50e-04 | 173 | 95 | 6 | GO:0009581 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 1.59e-04 | 175 | 95 | 6 | GO:0009582 | |
| GeneOntologyBiologicalProcess | axonogenesis | 2.79e-04 | 566 | 95 | 10 | GO:0007409 | |
| GeneOntologyBiologicalProcess | synapse organization | SPARC ACHE NTRK1 INSR LAMA5 ITGAM MAGI2 HMCN2 MDGA1 ATP2B2 EPHA7 | 3.10e-04 | 685 | 95 | 11 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell migration involved in vasculogenesis | 3.11e-04 | 6 | 95 | 2 | GO:0035441 | |
| GeneOntologyBiologicalProcess | neuron development | WDR36 CHODL ACHE NTRK1 FAT3 LAMA5 LAMB3 ADGRV1 WNK1 CREB1 SLC1A3 MAGI2 MRTFB HMCN2 CELSR3 ATP2B2 EPHA7 | 3.41e-04 | 1463 | 95 | 17 | GO:0048666 |
| GeneOntologyCellularComponent | dendrite | ACHE NTRK1 FAT3 INSR BACE1 SLC1A3 MAGI2 BRINP2 C4A C4B PLEC MDGA1 ATP2B2 EPHA7 | 4.09e-05 | 858 | 97 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | ACHE NTRK1 FAT3 INSR BACE1 SLC1A3 MAGI2 BRINP2 C4A C4B PLEC MDGA1 ATP2B2 EPHA7 | 4.19e-05 | 860 | 97 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | laminin-5 complex | 1.27e-04 | 4 | 97 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | basement membrane | 2.62e-04 | 122 | 97 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | somatodendritic compartment | ACHE NTRK1 FAT3 INSR BACE1 SLC1A3 MAGI2 HMCN2 BRINP2 C4A C4B PLEC MDGA1 ATP2B2 EPHA7 | 5.18e-04 | 1228 | 97 | 15 | GO:0036477 |
| GeneOntologyCellularComponent | symbiont cell surface | 5.86e-04 | 8 | 97 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | cell surface | SPARC IQGAP2 DSG2 PDGFRB ACHE NTRK1 INSR BACE1 ADGRV1 ITGAM SLC1A3 PKD1 OSMR MDGA1 | 5.96e-04 | 1111 | 97 | 14 | GO:0009986 |
| GeneOntologyCellularComponent | other organism part | 7.51e-04 | 9 | 97 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | laminin complex | 9.36e-04 | 10 | 97 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | neuronal cell body | ACHE NTRK1 INSR BACE1 SLC1A3 HMCN2 BRINP2 C4A C4B ATP2B2 EPHA7 | 1.68e-03 | 835 | 97 | 11 | GO:0043025 |
| HumanPheno | Congenital localized absence of skin | 4.54e-05 | 9 | 43 | 3 | HP:0007383 | |
| HumanPheno | Anti-complement component C1q antibody positivity | 1.03e-04 | 30 | 43 | 4 | HP:0034077 | |
| HumanPheno | Anti-ribosome Po antibody positivity | 1.03e-04 | 30 | 43 | 4 | HP:0034076 | |
| HumanPheno | Anti-phosphatidic acid antibody positivity | 1.03e-04 | 30 | 43 | 4 | HP:0034096 | |
| HumanPheno | Anti-Ro52/TRIM21 antibody positivity | 1.03e-04 | 30 | 43 | 4 | HP:0034093 | |
| HumanPheno | Anti-La/SS-B antibody positivity | 1.03e-04 | 30 | 43 | 4 | HP:0032235 | |
| HumanPheno | Anti-nucleoporin 62 antibody positivity | 1.03e-04 | 30 | 43 | 4 | HP:0033556 | |
| HumanPheno | Anti-titin antibody positivity | 1.03e-04 | 30 | 43 | 4 | HP:5000038 | |
| HumanPheno | Pyuria | 1.17e-04 | 31 | 43 | 4 | HP:0012085 | |
| HumanPheno | Lupus nephritis | 1.33e-04 | 32 | 43 | 4 | HP:0033726 | |
| HumanPheno | Anti-U1 ribonucleoprotein antibody positivity | 1.33e-04 | 32 | 43 | 4 | HP:0033028 | |
| HumanPheno | Anti-Sm antibody positivity | 1.33e-04 | 32 | 43 | 4 | HP:0033040 | |
| HumanPheno | Nephritis | 1.50e-04 | 141 | 43 | 7 | HP:0000123 | |
| HumanPheno | Blistering by histological location | 1.51e-04 | 13 | 43 | 3 | HP:0033801 | |
| HumanPheno | Extractable nuclear antigen positivity | 1.70e-04 | 34 | 43 | 4 | HP:0033476 | |
| HumanPheno | Anti-dsDNA antibody positivity | 1.70e-04 | 34 | 43 | 4 | HP:0020151 | |
| HumanPheno | Decreased circulating complement C4 concentration | 1.91e-04 | 35 | 43 | 4 | HP:0045042 | |
| HumanPheno | Serositis | 1.96e-04 | 103 | 43 | 6 | HP:0045073 | |
| HumanPheno | Erosion of oral mucosa | 2.18e-04 | 105 | 43 | 6 | HP:0031446 | |
| HumanPheno | Oral ulcer | 2.91e-04 | 71 | 43 | 5 | HP:0000155 | |
| HumanPheno | Discoid lupus rash | 2.92e-04 | 39 | 43 | 4 | HP:0007417 | |
| HumanPheno | Malar rash | 2.92e-04 | 39 | 43 | 4 | HP:0025300 | |
| HumanPheno | Glomerulonephritis | 2.96e-04 | 111 | 43 | 6 | HP:0000099 | |
| HumanPheno | Decreased circulating complement C3 concentration | 4.28e-04 | 43 | 43 | 4 | HP:0005421 | |
| HumanPheno | Arthropathy | 4.52e-04 | 78 | 43 | 5 | HP:0003040 | |
| HumanPheno | Abnormal pigmentation of the oral mucosa | 4.68e-04 | 44 | 43 | 4 | HP:0100669 | |
| HumanPheno | Malaise | 5.10e-04 | 45 | 43 | 4 | HP:0033834 | |
| MousePheno | absent podocytes | 2.02e-07 | 3 | 83 | 3 | MP:0008137 | |
| MousePheno | fused cornea and lens | 1.12e-05 | 24 | 83 | 4 | MP:0001307 | |
| MousePheno | absent pinna reflex | 1.43e-05 | 89 | 83 | 6 | MP:0006358 | |
| MousePheno | decreased podocyte number | 1.65e-05 | 9 | 83 | 3 | MP:0011753 | |
| MousePheno | abnormal head morphology | AGAP5 SPARC PDGFRB ACHE ESYT1 RDH10 KDM3B LAMA5 LAMB3 ERMP1 MORC2 NUBP2 PHC1 SETD2 AGAP7P PRDM15 AGAP4 AGAP6 GPR176 | 2.32e-05 | 1120 | 83 | 19 | MP:0000432 |
| MousePheno | right aortic arch | 2.76e-05 | 60 | 83 | 5 | MP:0004158 | |
| MousePheno | abnormal heart and great artery attachment | 2.87e-05 | 205 | 83 | 8 | MP:0010426 | |
| MousePheno | abnormal pinna reflex | 2.95e-05 | 101 | 83 | 6 | MP:0001485 | |
| MousePheno | abnormal heart and great vessel attachment | 3.18e-05 | 208 | 83 | 8 | MP:0010425 | |
| MousePheno | abnormal epidermal-dermal junction morphology | 4.27e-05 | 12 | 83 | 3 | MP:0011159 | |
| MousePheno | liver cyst | 4.27e-05 | 12 | 83 | 3 | MP:0003327 | |
| MousePheno | abnormal jaw morphology | AGAP5 SPARC PDGFRB ESYT1 LAMA5 LAMB3 MORC2 NUBP2 PKD1 AGAP7P AGAP4 AGAP6 | 6.48e-05 | 530 | 83 | 12 | MP:0000454 |
| MousePheno | abnormal tooth morphology | 1.09e-04 | 318 | 83 | 9 | MP:0002100 | |
| MousePheno | abnormal dental arch morphology | 1.12e-04 | 319 | 83 | 9 | MP:0030254 | |
| MousePheno | abnormal cardiac outflow tract development | 1.43e-04 | 134 | 83 | 6 | MP:0006126 | |
| MousePheno | abnormal left subclavian artery morphology | 1.54e-04 | 18 | 83 | 3 | MP:0010488 | |
| MousePheno | kidney failure | 1.56e-04 | 46 | 83 | 4 | MP:0003606 | |
| MousePheno | abnormal glomerular capillary morphology | 1.70e-04 | 47 | 83 | 4 | MP:0011320 | |
| MousePheno | abnormal kidney capillary morphology | 1.84e-04 | 48 | 83 | 4 | MP:0011310 | |
| MousePheno | abnormal viscerocranium morphology | AGAP5 SPARC PDGFRB ESYT1 LAMA5 LAMB3 MORC2 NUBP2 PKD1 AGAP7P AGAP4 AGAP6 | 1.87e-04 | 593 | 83 | 12 | MP:0005274 |
| MousePheno | abnormal common bile duct morphology | 2.07e-04 | 4 | 83 | 2 | MP:0009495 | |
| MousePheno | abnormal glomerular capillary endothelium morphology | 2.49e-04 | 21 | 83 | 3 | MP:0011453 | |
| MousePheno | double outlet right ventricle | 2.64e-04 | 150 | 83 | 6 | MP:0000284 | |
| MousePheno | abnormal facial morphology | AGAP5 SPARC PDGFRB ESYT1 RDH10 KDM3B LAMA5 LAMB3 ERMP1 MORC2 NUBP2 PHC1 AGAP7P AGAP4 AGAP6 | 2.67e-04 | 910 | 83 | 15 | MP:0003743 |
| MousePheno | abnormal artery morphology | 2.69e-04 | 440 | 83 | 10 | MP:0002191 | |
| MousePheno | cortical renal glomerulopathies | 3.26e-04 | 156 | 83 | 6 | MP:0000523 | |
| MousePheno | abnormal subclavian artery morphology | 3.36e-04 | 56 | 83 | 4 | MP:0003395 | |
| MousePheno | decreased mesangial cell number | 3.44e-04 | 5 | 83 | 2 | MP:0011428 | |
| MousePheno | abnormal craniofacial morphology | AGAP5 SPARC PDGFRB ACHE ESYT1 RDH10 KDM3B LAMA5 LAMB3 ERMP1 MORC2 NUBP2 PHC1 SETD2 MRTFB PKD1 AGAP7P AGAP4 AGAP6 | 3.48e-04 | 1372 | 83 | 19 | MP:0000428 |
| MousePheno | craniofacial phenotype | AGAP5 SPARC PDGFRB ACHE ESYT1 RDH10 KDM3B LAMA5 LAMB3 ERMP1 MORC2 NUBP2 PHC1 SETD2 MRTFB PKD1 AGAP7P AGAP4 AGAP6 | 3.48e-04 | 1372 | 83 | 19 | MP:0005382 |
| MousePheno | cornea opacity | 3.61e-04 | 159 | 83 | 6 | MP:0001314 | |
| MousePheno | abnormal aorta morphology | 3.75e-04 | 225 | 83 | 7 | MP:0000272 | |
| MousePheno | kidney inflammation | 5.32e-04 | 171 | 83 | 6 | MP:0001859 | |
| MousePheno | abnormal mouth morphology | AGAP5 SPARC ESYT1 LAMA5 LAMB3 ERMP1 MORC2 NUBP2 PHC1 AGAP7P AGAP4 AGAP6 | 5.67e-04 | 670 | 83 | 12 | MP:0000452 |
| MousePheno | small lung | 6.02e-04 | 115 | 83 | 5 | MP:0003641 | |
| MousePheno | abnormal cardiac muscle tissue morphology | 6.17e-04 | 489 | 83 | 10 | MP:0010630 | |
| MousePheno | abnormal kidney cortex morphology | 6.66e-04 | 324 | 83 | 8 | MP:0000521 | |
| MousePheno | persistent truncus arteriosus | 6.66e-04 | 67 | 83 | 4 | MP:0002633 | |
| MousePheno | abnormal muscle morphology | SP4 DSG2 PDGFRB RBL2 NTRK1 FAT3 INSR BACE1 MORC2 WNK1 CREB1 PHC1 EPG5 MRTFB PKD1 PLEC | 6.95e-04 | 1106 | 83 | 16 | MP:0002108 |
| MousePheno | renal/urinary system inflammation | 6.97e-04 | 180 | 83 | 6 | MP:0011762 | |
| MousePheno | abnormal aortic arch morphology | 7.03e-04 | 119 | 83 | 5 | MP:0004113 | |
| MousePheno | abnormal aorticopulmonary septum morphology | 7.05e-04 | 68 | 83 | 4 | MP:0010650 | |
| MousePheno | aorticopulmonary septal defect | 7.05e-04 | 68 | 83 | 4 | MP:0010651 | |
| MousePheno | increased circulating potassium level | 7.58e-04 | 121 | 83 | 5 | MP:0005627 | |
| MousePheno | abnormal renal/urinary system physiology | PDGFRB INSR LAMA5 TNIP1 ECI1 WNK1 TOE1 MAGI2 ARHGDIA PKD1 C4A C4B | 7.83e-04 | 695 | 83 | 12 | MP:0005502 |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 7.87e-04 | 70 | 83 | 4 | MP:0011497 | |
| MousePheno | abnormal podocyte morphology | 7.87e-04 | 70 | 83 | 4 | MP:0005326 | |
| MousePheno | abnormal kidney vasculature morphology | 9.21e-04 | 73 | 83 | 4 | MP:0000530 | |
| MousePheno | abnormal cranium morphology | AGAP5 SPARC PDGFRB ESYT1 LAMA5 LAMB3 MORC2 NUBP2 PHC1 PKD1 AGAP7P AGAP4 AGAP6 | 9.52e-04 | 813 | 83 | 13 | MP:0000438 |
| MousePheno | small frontonasal prominence | 9.53e-04 | 8 | 83 | 2 | MP:0030249 | |
| MousePheno | abnormal renal glomerulus morphology | 9.68e-04 | 264 | 83 | 7 | MP:0005325 | |
| MousePheno | abnormal iris morphology | 9.75e-04 | 192 | 83 | 6 | MP:0001322 | |
| MousePheno | abnormal craniofacial bone morphology | AGAP5 SPARC PDGFRB ESYT1 LAMA5 LAMB3 MORC2 NUBP2 PHC1 PKD1 AGAP7P AGAP4 AGAP6 | 1.11e-03 | 827 | 83 | 13 | MP:0002116 |
| MousePheno | aneurysm | 1.15e-03 | 35 | 83 | 3 | MP:0003279 | |
| MousePheno | vascular ring | 1.15e-03 | 35 | 83 | 3 | MP:0010466 | |
| MousePheno | abnormal anterior uvea morphology | 1.17e-03 | 199 | 83 | 6 | MP:0005194 | |
| MousePheno | abnormal lens development | 1.18e-03 | 78 | 83 | 4 | MP:0005545 | |
| MousePheno | abnormal thoracic aorta morphology | 1.20e-03 | 134 | 83 | 5 | MP:0010468 | |
| MousePheno | dermal-epidermal separation | 1.22e-03 | 9 | 83 | 2 | MP:0011160 | |
| MousePheno | absent radius | 1.22e-03 | 9 | 83 | 2 | MP:0000553 | |
| MousePheno | pillar cell degeneration | 1.22e-03 | 9 | 83 | 2 | MP:0004586 | |
| MousePheno | abnormal brain vasculature morphology | 1.24e-03 | 79 | 83 | 4 | MP:0004950 | |
| MousePheno | decreased cerebral infarct size | 1.25e-03 | 36 | 83 | 3 | MP:0006058 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 7.23e-06 | 8 | 96 | 3 | IPR019565 | |
| Domain | Thiol-ester_cl | 7.23e-06 | 8 | 96 | 3 | PF10569 | |
| Domain | MacrogloblnA2_CS | 7.23e-06 | 8 | 96 | 3 | IPR019742 | |
| Domain | EGF-like_CS | 7.96e-06 | 261 | 96 | 9 | IPR013032 | |
| Domain | EGF_2 | 8.99e-06 | 265 | 96 | 9 | PS01186 | |
| Domain | ArfGap | 1.41e-05 | 29 | 96 | 4 | SM00105 | |
| Domain | ARFGAP | 1.41e-05 | 29 | 96 | 4 | PS50115 | |
| Domain | ArfGap | 1.41e-05 | 29 | 96 | 4 | PF01412 | |
| Domain | ArfGAP | 1.41e-05 | 29 | 96 | 4 | IPR001164 | |
| Domain | A2M | 1.54e-05 | 10 | 96 | 3 | PF00207 | |
| Domain | A2M_N_2 | 1.54e-05 | 10 | 96 | 3 | IPR011625 | |
| Domain | A2M_comp | 1.54e-05 | 10 | 96 | 3 | IPR011626 | |
| Domain | A2M_recep | 1.54e-05 | 10 | 96 | 3 | PF07677 | |
| Domain | A2M_comp | 1.54e-05 | 10 | 96 | 3 | PF07678 | |
| Domain | A2M_N | 1.54e-05 | 10 | 96 | 3 | PF01835 | |
| Domain | A2M_N | 1.54e-05 | 10 | 96 | 3 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.54e-05 | 10 | 96 | 3 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.54e-05 | 10 | 96 | 3 | PS00477 | |
| Domain | A2M_N_2 | 1.54e-05 | 10 | 96 | 3 | PF07703 | |
| Domain | Macroglobln_a2 | 1.54e-05 | 10 | 96 | 3 | IPR001599 | |
| Domain | Cadherin_CS | 2.08e-05 | 109 | 96 | 6 | IPR020894 | |
| Domain | CADHERIN_1 | 2.56e-05 | 113 | 96 | 6 | PS00232 | |
| Domain | Cadherin | 2.56e-05 | 113 | 96 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 2.69e-05 | 114 | 96 | 6 | PS50268 | |
| Domain | - | 2.69e-05 | 114 | 96 | 6 | 2.60.40.60 | |
| Domain | CA | 2.82e-05 | 115 | 96 | 6 | SM00112 | |
| Domain | EGF | 2.85e-05 | 235 | 96 | 8 | SM00181 | |
| Domain | Cadherin-like | 2.96e-05 | 116 | 96 | 6 | IPR015919 | |
| Domain | EGF_Lam | 3.04e-05 | 35 | 96 | 4 | SM00180 | |
| Domain | Laminin_EGF | 3.04e-05 | 35 | 96 | 4 | PF00053 | |
| Domain | Cadherin | 3.27e-05 | 118 | 96 | 6 | IPR002126 | |
| Domain | LAM_G_DOMAIN | 4.23e-05 | 38 | 96 | 4 | PS50025 | |
| Domain | Laminin_EGF | 4.23e-05 | 38 | 96 | 4 | IPR002049 | |
| Domain | EGF-like_dom | 4.30e-05 | 249 | 96 | 8 | IPR000742 | |
| Domain | EGF_1 | 5.09e-05 | 255 | 96 | 8 | PS00022 | |
| Domain | Laminin_G_2 | 5.20e-05 | 40 | 96 | 4 | PF02210 | |
| Domain | LamG | 7.60e-05 | 44 | 96 | 4 | SM00282 | |
| Domain | ParA | 7.82e-05 | 3 | 96 | 2 | PF10609 | |
| Domain | Mrp/NBP35_ATP-bd | 7.82e-05 | 3 | 96 | 2 | IPR019591 | |
| Domain | Mrp_CS | 7.82e-05 | 3 | 96 | 2 | IPR000808 | |
| Domain | YlxH/NBP35 | 7.82e-05 | 3 | 96 | 2 | IPR033756 | |
| Domain | MRP | 7.82e-05 | 3 | 96 | 2 | PS01215 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 1.02e-04 | 18 | 96 | 3 | IPR008930 | |
| Domain | - | 1.30e-04 | 95 | 96 | 5 | 2.60.120.200 | |
| Domain | ConA-like_dom | 1.36e-04 | 219 | 96 | 7 | IPR013320 | |
| Domain | Laminin_G | 2.25e-04 | 58 | 96 | 4 | IPR001791 | |
| Domain | Anaphylatoxin_comp_syst | 2.59e-04 | 5 | 96 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 2.59e-04 | 5 | 96 | 2 | IPR001840 | |
| Domain | FN3 | 3.86e-04 | 185 | 96 | 6 | SM00060 | |
| Domain | EGF_LAM_2 | 4.83e-04 | 30 | 96 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 4.83e-04 | 30 | 96 | 3 | PS01248 | |
| Domain | ANATO | 5.40e-04 | 7 | 96 | 2 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 5.40e-04 | 7 | 96 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 5.40e-04 | 7 | 96 | 2 | PS01177 | |
| Domain | ANATO | 5.40e-04 | 7 | 96 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 5.40e-04 | 7 | 96 | 2 | IPR000020 | |
| Domain | FN3 | 5.68e-04 | 199 | 96 | 6 | PS50853 | |
| Domain | GPS | 7.02e-04 | 34 | 96 | 3 | SM00303 | |
| Domain | A2M_N_2 | 7.17e-04 | 8 | 96 | 2 | SM01359 | |
| Domain | - | 7.17e-04 | 8 | 96 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 7.17e-04 | 8 | 96 | 2 | SM01361 | |
| Domain | A2M | 7.17e-04 | 8 | 96 | 2 | SM01360 | |
| Domain | FN3_dom | 7.34e-04 | 209 | 96 | 6 | IPR003961 | |
| Domain | GPS | 7.64e-04 | 35 | 96 | 3 | PF01825 | |
| Domain | GPS | 8.31e-04 | 36 | 96 | 3 | PS50221 | |
| Domain | GPS | 9.01e-04 | 37 | 96 | 3 | IPR000203 | |
| Domain | Ig-like_fold | PDGFRB NTRK1 INSR VSIG1 TGM5 IGDCC4 HMCN2 RIMBP2 OSMR MDGA1 EPHA7 | 9.91e-04 | 706 | 96 | 11 | IPR013783 |
| Domain | Tyr_kinase_cat_dom | 1.10e-03 | 88 | 96 | 4 | IPR020635 | |
| Domain | TyrKc | 1.10e-03 | 88 | 96 | 4 | SM00219 | |
| Domain | EGF_3 | 1.34e-03 | 235 | 96 | 6 | PS50026 | |
| Domain | Fol_N | 1.40e-03 | 11 | 96 | 2 | IPR003645 | |
| Domain | Tyr_kinase_rcpt_2_CS | 1.40e-03 | 11 | 96 | 2 | IPR002011 | |
| Domain | FOLN | 1.40e-03 | 11 | 96 | 2 | SM00274 | |
| Domain | fn3 | 1.49e-03 | 162 | 96 | 5 | PF00041 | |
| Domain | PROTEIN_KINASE_TYR | 1.58e-03 | 97 | 96 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.58e-03 | 97 | 96 | 4 | IPR008266 | |
| Domain | RECEPTOR_TYR_KIN_II | 1.67e-03 | 12 | 96 | 2 | PS00239 | |
| Domain | - | 1.67e-03 | 12 | 96 | 2 | 1.50.10.20 | |
| Domain | - | 2.15e-03 | 663 | 96 | 10 | 2.60.40.10 | |
| Domain | RasGAP | 2.29e-03 | 14 | 96 | 2 | SM00323 | |
| Domain | RasGAP_CS | 2.29e-03 | 14 | 96 | 2 | IPR023152 | |
| Domain | WW_DOMAIN_1 | 2.29e-03 | 51 | 96 | 3 | PS01159 | |
| Domain | WW_DOMAIN_2 | 2.29e-03 | 51 | 96 | 3 | PS50020 | |
| Domain | WW_dom | 2.42e-03 | 52 | 96 | 3 | IPR001202 | |
| Domain | RasGAP | 2.63e-03 | 15 | 96 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 2.63e-03 | 15 | 96 | 2 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 2.63e-03 | 15 | 96 | 2 | PS50018 | |
| Domain | Laminin_N | 2.99e-03 | 16 | 96 | 2 | IPR008211 | |
| Domain | LamNT | 2.99e-03 | 16 | 96 | 2 | SM00136 | |
| Domain | - | 2.99e-03 | 16 | 96 | 2 | 1.10.506.10 | |
| Domain | LAMININ_NTER | 2.99e-03 | 16 | 96 | 2 | PS51117 | |
| Domain | Laminin_N | 2.99e-03 | 16 | 96 | 2 | PF00055 | |
| Domain | C345C | 3.38e-03 | 17 | 96 | 2 | SM00643 | |
| Domain | EGF_CA | 3.62e-03 | 122 | 96 | 4 | SM00179 | |
| Domain | RasGAP_dom | 3.79e-03 | 18 | 96 | 2 | IPR001936 | |
| Domain | EGF-like_Ca-bd_dom | 3.84e-03 | 124 | 96 | 4 | IPR001881 | |
| Domain | NTR | 4.22e-03 | 19 | 96 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 4.22e-03 | 19 | 96 | 2 | IPR018933 | |
| Domain | Pkinase_Tyr | 4.42e-03 | 129 | 96 | 4 | PF07714 | |
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 7.09e-09 | 9 | 97 | 4 | 12640130 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 1.18e-08 | 10 | 97 | 4 | 20664521 | |
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 1.85e-08 | 11 | 97 | 4 | 15381706 | |
| Pubmed | 3.99e-08 | 13 | 97 | 4 | 27713690 | ||
| Pubmed | 5.57e-08 | 14 | 97 | 4 | 22453919 | ||
| Pubmed | Astrocytic Insulin Signaling Couples Brain Glucose Uptake with Nutrient Availability. | 8.40e-08 | 4 | 97 | 3 | 27518562 | |
| Pubmed | 2.09e-07 | 5 | 97 | 3 | 9382884 | ||
| Pubmed | 1.17e-06 | 8 | 97 | 3 | 24474777 | ||
| Pubmed | AGAP5 KDM3B LAMA5 ERMP1 ADGRV1 CELSR3 NBEAL2 AGAP7P AGAP4 AGAP6 | 2.35e-06 | 529 | 97 | 10 | 14621295 | |
| Pubmed | 4.54e-06 | 12 | 97 | 3 | 18524992 | ||
| Pubmed | WDR36 IQGAP2 DSG2 ESYT1 RBMS1 RDH10 MORC2 NUBPL TOE1 ARHGDIA PRRC2C C4B PLEC LSM14B LRRFIP2 | 5.95e-06 | 1371 | 97 | 15 | 36244648 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | WDR36 PCNX3 RBMS1 PSMD2 NUBP2 TGM5 ARHGDIA CROCC2 C4A LSM14B EPHA7 | 6.42e-06 | 732 | 97 | 11 | 34732716 |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 7.70e-06 | 2 | 97 | 2 | 16565498 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 15998580 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 19062096 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 7.70e-06 | 2 | 97 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 7.70e-06 | 2 | 97 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 7.70e-06 | 2 | 97 | 2 | 17645767 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 7.70e-06 | 2 | 97 | 2 | 27758680 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 22387014 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 7.70e-06 | 2 | 97 | 2 | 23749435 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 23918728 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 7.70e-06 | 2 | 97 | 2 | 3037333 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 11726230 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 7.70e-06 | 2 | 97 | 2 | 6950384 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 7.70e-06 | 2 | 97 | 2 | 8428773 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 7.70e-06 | 2 | 97 | 2 | 21345967 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 2572548 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 2302180 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 7.70e-06 | 2 | 97 | 2 | 18091514 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 29080553 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 7.70e-06 | 2 | 97 | 2 | 25339671 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 17728371 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 6149580 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 6149581 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 12115608 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 3542363 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 2387317 | ||
| Pubmed | Protein kinase D activation stimulates the transcription of the insulin receptor gene. | 7.70e-06 | 2 | 97 | 2 | 20674666 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 16908004 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 7365238 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 7391573 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 17971360 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 7.70e-06 | 2 | 97 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 7.70e-06 | 2 | 97 | 2 | 17971229 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 6881182 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 31703329 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 7.70e-06 | 2 | 97 | 2 | 17921792 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 7.70e-06 | 2 | 97 | 2 | 6978711 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 35898513 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 28873507 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 276882 | ||
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 7.70e-06 | 2 | 97 | 2 | 6832377 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 3794341 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 30093630 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 22785613 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 32691186 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 7.70e-06 | 2 | 97 | 2 | 8390682 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 7.70e-06 | 2 | 97 | 2 | 3902619 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 7.70e-06 | 2 | 97 | 2 | 7373044 | |
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 7.70e-06 | 2 | 97 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 7.70e-06 | 2 | 97 | 2 | 1357031 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 34203347 | ||
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 7.70e-06 | 2 | 97 | 2 | 16098595 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 7.70e-06 | 2 | 97 | 2 | 15787745 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 28855330 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 30026462 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 6559257 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 7.70e-06 | 2 | 97 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 7.70e-06 | 2 | 97 | 2 | 20506482 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 12480675 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 26800705 | ||
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 7.70e-06 | 2 | 97 | 2 | 15390104 | |
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 7.70e-06 | 2 | 97 | 2 | 1699796 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 7.70e-06 | 2 | 97 | 2 | 2997024 | |
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 7.70e-06 | 2 | 97 | 2 | 3624865 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 21857912 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 7.70e-06 | 2 | 97 | 2 | 4514997 | |
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 7.70e-06 | 2 | 97 | 2 | 5919331 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 7.70e-06 | 2 | 97 | 2 | 3167981 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 7545960 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 30041577 | ||
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 7.70e-06 | 2 | 97 | 2 | 3862104 | |
| Pubmed | The BS variant of C4 protects against age-related loss of white matter microstructural integrity. | 7.70e-06 | 2 | 97 | 2 | 34358307 | |
| Pubmed | Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. | 7.70e-06 | 2 | 97 | 2 | 18360261 | |
| Pubmed | Schizophrenia risk from complex variation of complement component 4. | 7.70e-06 | 2 | 97 | 2 | 26814963 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 8132550 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 2395880 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 26814708 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 6192448 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 6167582 | ||
| Cytoband | 1q24 | 8.19e-04 | 20 | 97 | 2 | 1q24 | |
| Cytoband | 3p21.31 | 1.27e-03 | 100 | 97 | 3 | 3p21.31 | |
| Cytoband | 5q33.1 | 1.39e-03 | 26 | 97 | 2 | 5q33.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q33 | 2.05e-03 | 118 | 97 | 3 | chr5q33 | |
| Cytoband | 10q11.23 | 2.24e-03 | 33 | 97 | 2 | 10q11.23 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 4.21e-06 | 9 | 68 | 3 | 1234 | |
| GeneFamily | ArfGAPs | 6.90e-06 | 33 | 68 | 4 | 395 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 3.33e-05 | 17 | 68 | 3 | 1291 | |
| GeneFamily | Immunoglobulin like domain containing | 8.65e-05 | 193 | 68 | 6 | 594 | |
| GeneFamily | Complement system|Sushi domain containing | 3.32e-04 | 36 | 68 | 3 | 492 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 3.61e-04 | 37 | 68 | 3 | 454 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 4.55e-04 | 40 | 68 | 3 | 321 | |
| GeneFamily | Laminin subunits | 8.98e-04 | 12 | 68 | 2 | 626 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.07e-03 | 206 | 68 | 5 | 682 | |
| GeneFamily | Cadherin related | 1.83e-03 | 17 | 68 | 2 | 24 | |
| GeneFamily | Fibronectin type III domain containing | 3.10e-03 | 160 | 68 | 4 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.17e-03 | 161 | 68 | 4 | 593 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.04e-02 | 41 | 68 | 2 | 1298 | |
| GeneFamily | Ankyrin repeat domain containing | 1.31e-02 | 242 | 68 | 4 | 403 | |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 2.48e-07 | 37 | 97 | 5 | MM1121 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_DN | 1.12e-06 | 209 | 97 | 8 | MM1058 | |
| Coexpression | SIMBULAN_UV_RESPONSE_NORMAL_DN | 6.64e-06 | 33 | 97 | 4 | M16114 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN | 2.14e-05 | 44 | 97 | 4 | MM485 | |
| Coexpression | GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP | 4.27e-05 | 171 | 97 | 6 | M7105 | |
| Coexpression | JI_RESPONSE_TO_FSH_DN | 4.49e-05 | 53 | 97 | 4 | M17537 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | 5.35e-05 | 574 | 97 | 10 | M39056 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_DN | 5.88e-05 | 111 | 97 | 5 | MM1111 | |
| Coexpression | INGRAM_SHH_TARGETS_DN | 8.88e-05 | 63 | 97 | 4 | M1322 | |
| Coexpression | INGRAM_SHH_TARGETS_DN | 9.45e-05 | 64 | 97 | 4 | MM551 | |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 9.89e-05 | 199 | 97 | 6 | M9443 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN | 1.02e-04 | 200 | 97 | 6 | M5212 | |
| Coexpression | GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_UP | 1.02e-04 | 200 | 97 | 6 | M8517 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Club|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.55e-07 | 197 | 97 | 7 | 01e9505d947e5a5f005d1eab96301f84fc194809 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-07 | 197 | 97 | 7 | 5fbbc570a4e77c703f569a4f85ce2d8af67d6297 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.83e-07 | 200 | 97 | 7 | ed4a41cb6782541d8fc928aaa12cf03bc1c630a2 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 3.03e-06 | 183 | 97 | 6 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 3.23e-06 | 185 | 97 | 6 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.43e-06 | 187 | 97 | 6 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.76e-06 | 190 | 97 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | facs-Skin|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-06 | 191 | 97 | 6 | ae524103331fa53fa82888dbb567fc36abcee7e0 | |
| ToppCell | (5)_Epi_basal|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.88e-06 | 191 | 97 | 6 | 6bda3d5a8a391d41bb4d65872492e6c094bcc4d4 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 192 | 97 | 6 | ec1fd2fb6e71f87189d66261909a84e2be63cacb | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.00e-06 | 192 | 97 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 4.24e-06 | 194 | 97 | 6 | 7c6c0376603e5fcb64814fd6204d153629c2fbf5 | |
| ToppCell | Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.37e-06 | 195 | 97 | 6 | eb104f3bb08ab9eca31273c0523a5c90de1f30a9 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.50e-06 | 196 | 97 | 6 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.63e-06 | 197 | 97 | 6 | 88a86286b9c3ea3b076d7464faec42d0392ee7f8 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.63e-06 | 197 | 97 | 6 | 2773d2eb5f232a7e49da116efffcb6bf5eb90810 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Macroglial-Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.77e-06 | 198 | 97 | 6 | 715ecad21f572b195ff3b78216b1a7b32bbb4ace | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Macroglial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.77e-06 | 198 | 97 | 6 | 9d03768f8b6c74e060c5f045508538f9b331f469 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 4.91e-06 | 199 | 97 | 6 | 75ff9a5df156c6632883eab79573f1c02c985803 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.91e-06 | 199 | 97 | 6 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-RGCs_3|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 5.05e-06 | 200 | 97 | 6 | 55a1df656545ff078b727d55e4d65d61ddb5c41f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 5.05e-06 | 200 | 97 | 6 | 792fef1f3e47ce5c131fedfad55075fc254aeead | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.72e-05 | 161 | 97 | 5 | 8ec923c230a7a3cce5edf2a736b3a00d607c698a | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 3.53e-05 | 170 | 97 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-mLTo|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.53e-05 | 170 | 97 | 5 | 7653f1205d4e62abe7e31b1d76f9bbd665e45667 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.74e-05 | 172 | 97 | 5 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.95e-05 | 174 | 97 | 5 | edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.95e-05 | 174 | 97 | 5 | 65539f69100db0b7d90b1b39ee15ab8281f86461 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 177 | 97 | 5 | e5070934c674a46e070b0d52b9a374516bf6aea1 | |
| ToppCell | metastatic_Brain-Fibroblasts-Undetermined|metastatic_Brain / Location, Cell class and cell subclass | 4.28e-05 | 177 | 97 | 5 | 54f39be5d90363cfd44dea1a96ae06d3143aa795 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 177 | 97 | 5 | b37d821f4f3204daf7c568ac17a0af0ba97273d6 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.64e-05 | 180 | 97 | 5 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 181 | 97 | 5 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 4.76e-05 | 181 | 97 | 5 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 181 | 97 | 5 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 5.02e-05 | 183 | 97 | 5 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.02e-05 | 183 | 97 | 5 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 5.02e-05 | 183 | 97 | 5 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.02e-05 | 183 | 97 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.02e-05 | 183 | 97 | 5 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 5.02e-05 | 183 | 97 | 5 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.02e-05 | 183 | 97 | 5 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.02e-05 | 183 | 97 | 5 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 5.02e-05 | 183 | 97 | 5 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.56e-05 | 187 | 97 | 5 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 187 | 97 | 5 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.70e-05 | 188 | 97 | 5 | 2b8d70f761eda5509f21845a87cdb3602a639dd7 | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.85e-05 | 189 | 97 | 5 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 5.99e-05 | 190 | 97 | 5 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.15e-05 | 191 | 97 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.15e-05 | 191 | 97 | 5 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.30e-05 | 192 | 97 | 5 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG-34|World / Primary Cells by Cluster | 6.46e-05 | 193 | 97 | 5 | d55f792eb3db10452347681131e07e041348fd89 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.46e-05 | 193 | 97 | 5 | c5bd0ed6f57459e54d2463318e8d9b1879718e63 | |
| ToppCell | Non-neuronal-Non-dividing|World / Primary Cells by Cluster | 6.61e-05 | 194 | 97 | 5 | 0add09d97192b34bd506209ab5f1a77182f498fc | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 194 | 97 | 5 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.61e-05 | 194 | 97 | 5 | a281ebab117589fc922ead0a712cfe0a844c94ac | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.61e-05 | 194 | 97 | 5 | ad3eb98f94a007c5988ede06238255f5b03bee6e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 194 | 97 | 5 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG|World / Primary Cells by Cluster | 6.61e-05 | 194 | 97 | 5 | 3a4bf6a7fac0e5bdbb4bb17041806d06a75974d9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.61e-05 | 194 | 97 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia|World / Primary Cells by Cluster | 6.61e-05 | 194 | 97 | 5 | 1445b7611c2b1ab9b320f330d17d70117892cc28 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.61e-05 | 194 | 97 | 5 | c45e9d09b5cd6973de6c3f1713b3bf36fa4bfe57 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.94e-05 | 196 | 97 | 5 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.94e-05 | 196 | 97 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 197 | 97 | 5 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 7.11e-05 | 197 | 97 | 5 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.11e-05 | 197 | 97 | 5 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-late-42|World / Primary Cells by Cluster | 7.11e-05 | 197 | 97 | 5 | 0057aa4bce8684711b061710eab1d2b85e14e055 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 7.11e-05 | 197 | 97 | 5 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.11e-05 | 197 | 97 | 5 | 49689a03ab31e53386dbe15c77c09ca3a14ebf4e | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.11e-05 | 197 | 97 | 5 | 965d5a3f8c9b12cb8a8d3429702ae29ebd8c6122 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.11e-05 | 197 | 97 | 5 | 69d5b8588046d119b5dff9a7fd6f49e97e00a5b7 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial-Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.11e-05 | 197 | 97 | 5 | 3f088eb29197bc575400d6dafd8083e69e4a149f | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-late|World / Primary Cells by Cluster | 7.11e-05 | 197 | 97 | 5 | 9a65a54e097947601d8e382c4f4b4f5c2c1df51c | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.11e-05 | 197 | 97 | 5 | e6cbfa267eb2e05b441fd034786faae07bb0e081 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Radial_glial-oRG|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.28e-05 | 198 | 97 | 5 | 72dc49aa107d0cc6206eb67b577c73e190855125 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.28e-05 | 198 | 97 | 5 | 691a2f1779225e5519155460eeb6a2aac5f67a92 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-IN_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.28e-05 | 198 | 97 | 5 | 3811d9e3e54bbe8b208c591697e43b55ab5bbf0e | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-20|World / Primary Cells by Cluster | 7.28e-05 | 198 | 97 | 5 | bce0bc1e3f2257e0f42a1fa6e5b57cf71e4514ba | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.28e-05 | 198 | 97 | 5 | aed0476248e9637897eefb1623ec4035f2dacd82 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.28e-05 | 198 | 97 | 5 | e115eea04012e9e492e923ed080e1723c38d14fd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.28e-05 | 198 | 97 | 5 | 33d1e0b6f57663544bee0ffdde83a65da764d44c | |
| ToppCell | Severe_COVID-19-Epithelial-AT1/AT2|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 7.28e-05 | 198 | 97 | 5 | 43e33d28d9de5033bd00d39be953542a225236ed | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 7.28e-05 | 198 | 97 | 5 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.46e-05 | 199 | 97 | 5 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.46e-05 | 199 | 97 | 5 | 0cdbedf09ec72734b86ddab3fec562e066afed92 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Radial_glial-oRG/Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.46e-05 | 199 | 97 | 5 | 0b96fad1be02f0fe7a608207770cc56a6b6b291e | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.46e-05 | 199 | 97 | 5 | f8846446ebbc4948cdc69640782db1358bbdc486 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 7.46e-05 | 199 | 97 | 5 | fe9f5bc317be0c35bd96311bf0b3c7b91d98acc5 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Radial_glial-oRG|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.46e-05 | 199 | 97 | 5 | 9762611a142a8e45d8ecbbedbd4a0cb044c51145 | |
| ToppCell | Sepsis-URO|Sepsis / Disease, condition lineage and cell class | 7.46e-05 | 199 | 97 | 5 | 8e6dac82d1d0e759cd567f9c95b70cb4801d7caf | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.46e-05 | 199 | 97 | 5 | 3e35ee426ef06f9af568c37349b62dd1ee9b97ea | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Radial_glial|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.46e-05 | 199 | 97 | 5 | 6fd9774f18da3e6f114427f55a8879ac90c41350 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Radial_glial-oRG|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.46e-05 | 199 | 97 | 5 | 151bda6821b52cfb4491474892ecb45781522837 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.46e-05 | 199 | 97 | 5 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.46e-05 | 199 | 97 | 5 | bf138cc692df727e087d140c014149ee5da00d9d | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Radial_glial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-05 | 200 | 97 | 5 | 4477591efada4007bab1f689017e3ac285267d29 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 7.64e-05 | 200 | 97 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Interneuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-05 | 200 | 97 | 5 | a6500d0d2e8bcac92381ab771dbdee66b0e1d48e | |
| Computational | Genes in the cancer module 51. | 5.84e-05 | 36 | 64 | 4 | MODULE_51 | |
| Drug | Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; HL60; HT_HG-U133A | 1.82e-06 | 194 | 97 | 8 | 2391_UP | |
| Disease | cerebral palsy (implicated_via_orthology) | 2.18e-08 | 10 | 96 | 4 | DOID:1969 (implicated_via_orthology) | |
| Disease | Lupus Erythematosus, Systemic | 3.60e-06 | 71 | 96 | 5 | C0024141 | |
| Disease | Schizophrenia | SP4 PDGFRB ACHE NTRK1 BACE1 ITGAM CREB1 SLC1A3 MAGI2 UCP2 MDGA1 MEGF10 | 2.98e-05 | 883 | 96 | 12 | C0036341 |
| Disease | hereditary sensory neuropathy (is_implicated_in) | 6.26e-05 | 4 | 96 | 2 | DOID:0050548 (is_implicated_in) | |
| Disease | medial orbital frontal cortex volume measurement | 7.29e-05 | 25 | 96 | 3 | EFO_0010315 | |
| Disease | bipolar I disorder | 1.00e-04 | 141 | 96 | 5 | EFO_0009963 | |
| Disease | Hyperinsulinism | 1.03e-04 | 28 | 96 | 3 | C0020459 | |
| Disease | Hirschsprung's disease (is_marker_for) | 1.56e-04 | 6 | 96 | 2 | DOID:10487 (is_marker_for) | |
| Disease | Bipolar Disorder | 1.68e-04 | 477 | 96 | 8 | C0005586 | |
| Disease | Alzheimer disease | 1.88e-04 | 485 | 96 | 8 | MONDO_0004975 | |
| Disease | polycystic liver disease (implicated_via_orthology) | 2.18e-04 | 7 | 96 | 2 | DOID:0050770 (implicated_via_orthology) | |
| Disease | beta-defensin 119 measurement | 2.90e-04 | 8 | 96 | 2 | EFO_0801419 | |
| Disease | Acute Confusional Senile Dementia | 3.13e-04 | 99 | 96 | 4 | C0546126 | |
| Disease | Alzheimer's Disease, Focal Onset | 3.13e-04 | 99 | 96 | 4 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 3.13e-04 | 99 | 96 | 4 | C0750901 | |
| Disease | Presenile dementia | 3.13e-04 | 99 | 96 | 4 | C0011265 | |
| Disease | Alzheimer Disease, Late Onset | 3.13e-04 | 99 | 96 | 4 | C0494463 | |
| Disease | Familial Alzheimer Disease (FAD) | 3.25e-04 | 100 | 96 | 4 | C0276496 | |
| Disease | Alzheimer's Disease | 3.37e-04 | 101 | 96 | 4 | C0002395 | |
| Disease | creatinine measurement | ZBTB17 LAMA5 PSMD2 ADGRV1 SLC1A3 MMP24 CELSR3 PRRC2C PLEC LSM14B MEGF10 | 3.92e-04 | 995 | 96 | 11 | EFO_0004518 |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 7.98e-04 | 13 | 96 | 2 | C0270914 | |
| Disease | Libman-Sacks Disease | 9.04e-04 | 58 | 96 | 3 | C0242380 | |
| Disease | platelet crit | SP4 IQGAP2 NUP210L LAMA5 ZNF407 ADGRV1 EPG5 RNF150 PLEC RASAL2 | 1.07e-03 | 952 | 96 | 10 | EFO_0007985 |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 1.20e-03 | 64 | 96 | 3 | DOID:224 (implicated_via_orthology) | |
| Disease | hearing loss | 1.37e-03 | 67 | 96 | 3 | EFO_0004238 | |
| Disease | Antibody Deficiency Syndrome | 1.38e-03 | 17 | 96 | 2 | C0003257 | |
| Disease | caudal anterior cingulate cortex volume measurement | 1.38e-03 | 17 | 96 | 2 | EFO_0010289 | |
| Disease | schizophrenia (implicated_via_orthology) | 1.43e-03 | 68 | 96 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | renal cell carcinoma (is_implicated_in) | 1.50e-03 | 69 | 96 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | perceived unattractiveness to mosquitos measurement | 1.69e-03 | 72 | 96 | 3 | EFO_0008380 | |
| Disease | dilated cardiomyopathy | 1.92e-03 | 20 | 96 | 2 | EFO_0000407 | |
| Disease | Lewy Body Disease | 2.32e-03 | 22 | 96 | 2 | C0752347 | |
| Disease | carotid artery disease (is_implicated_in) | 2.32e-03 | 22 | 96 | 2 | DOID:3407 (is_implicated_in) | |
| Disease | Immunologic Deficiency Syndromes | 2.53e-03 | 23 | 96 | 2 | C0021051 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 3.00e-03 | 88 | 96 | 3 | EFO_0803332 | |
| Disease | systemic scleroderma, systemic lupus erythematosus | 3.24e-03 | 26 | 96 | 2 | EFO_0000717, MONDO_0007915 | |
| Disease | Endogenous Hyperinsulinism | 3.24e-03 | 26 | 96 | 2 | C1257963 | |
| Disease | Exogenous Hyperinsulinism | 3.24e-03 | 26 | 96 | 2 | C1257964 | |
| Disease | Compensatory Hyperinsulinemia | 3.24e-03 | 26 | 96 | 2 | C1257965 | |
| Disease | platelet component distribution width | 3.25e-03 | 755 | 96 | 8 | EFO_0007984 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VGVPQVSDLAAEAVV | 396 | P22303 | |
| AAAVQPAEVTVEVGE | 46 | Q96P64 | |
| NEVFEVIVTSVPGQE | 701 | Q9BSJ8 | |
| ISVSTQPNEVGPVAV | 1131 | Q9HCE0 | |
| GPNVTVRANIAAITE | 151 | P56817 | |
| QEVVGGFPSQAQVTV | 326 | P11597 | |
| DGIDSVIVVDNVPQV | 181 | P55884 | |
| VQEVPVGLVQPASAT | 1541 | P0C0L5 | |
| QADVVVAEVTQPSLG | 86 | O43598 | |
| VVDAVEGVCPQTQAV | 116 | Q7Z2Z2 | |
| QPTNVVAIVTEATGV | 5171 | Q8WXG9 | |
| ASVVAQEVFQSGIIP | 311 | Q7Z2K6 | |
| VQIPVAEIVVGDIAQ | 201 | Q01814 | |
| AAAVQPAEVTVEVGE | 46 | Q5VW22 | |
| GQDVVIVAAPENTTV | 241 | Q8TDY8 | |
| ALVVTTPQAVSVGDV | 156 | Q9Y5Y2 | |
| VIANNSVGASPASVI | 506 | Q99650 | |
| TAVPVEEASGQQQVA | 376 | P29558 | |
| ASVPVEAFVGLQIQV | 141 | A6NJW4 | |
| AVPVQNVSGETVSVT | 706 | Q08999 | |
| PNIAVGQNVTVTERV | 1036 | Q14126 | |
| VNETLVVNPGENVTV | 246 | Q8NFP4 | |
| EVEPTVSVVQGVFSN | 1076 | Q96KG7 | |
| VTINDVPGSVNAVAV | 591 | Q9Y5R2 | |
| VGRAEVSVQVNVSFP | 271 | P04629 | |
| VVNGNGVVVTPESSE | 241 | Q86UL8 | |
| VVASVPVFAVTNVAD | 171 | Q14439 | |
| PVIQAVGSSSAVNVI | 1866 | Q8IWI9 | |
| EPPTQVSVVQDGVAT | 2271 | Q8NDA2 | |
| TASDVVQPAAVQAQG | 196 | Q9BX40 | |
| EAQVGVEQAASEPVV | 526 | Q9H6A9 | |
| VQENSPSGTQVIVVA | 1041 | Q9NYQ8 | |
| QEVPVGQAEQQSVVS | 671 | Q9ULH7 | |
| SVVSAALVAEPVQNG | 901 | Q9UJF2 | |
| EQVGQGIVASAAVVT | 411 | Q7LBC6 | |
| DVGNVTVAVPTVAAF | 766 | P06213 | |
| TGSDVDVQLQVAVPQ | 1091 | O15230 | |
| SEAAAVQPVIGISQR | 141 | Q96FE7 | |
| PGTVVFQVIAVDNDT | 691 | Q9BZA7 | |
| EQNPVIIIAVVAVAG | 551 | Q15375 | |
| AVFPQNGLVVSSVDV | 626 | Q14764 | |
| EPVAGAITVVSQEAA | 541 | Q9Y608 | |
| EEVGPVAQQAIAVAE | 871 | Q9Y6X9 | |
| ASVGVAPEVALVDVN | 681 | Q9Y5I2 | |
| GIVDQVVPEEQVQST | 221 | P42126 | |
| VSADPNVPNVVVTGL | 61 | P52565 | |
| QAGVQEPTATVARVQ | 76 | H7BZ55 | |
| QVTVDGEAVALPVAV | 4926 | Q9Y6R7 | |
| VPIQANETLVGAVIN | 201 | P43003 | |
| SPREVTVQAQLVAQG | 56 | Q8IZJ3 | |
| RVTEIVGVVSVQPAN | 1376 | Q8TDW7 | |
| AAAVQPAEVTVEVGE | 46 | Q5VUJ5 | |
| VPSNQVVVQAASGDV | 221 | P16220 | |
| ILAVAVGFPVSQDQE | 11 | Q8NFU4 | |
| STVAVQSVNAGAPLI | 406 | Q15723 | |
| PAVTEQEVAQVASAI | 641 | Q13751 | |
| VDVSVFDVVANPGQT | 51 | Q12794 | |
| NEGVAQVVAVGSNVT | 106 | Q9BV79 | |
| IVGSVVAQITAVDPD | 1081 | Q9NYQ7 | |
| VQEVPVGLVQPASAT | 1541 | P0C0L4 | |
| VQLSVSQNIPITGAV | 191 | Q8TB37 | |
| EPFGVNQTTITGVQV | 1361 | Q5VU65 | |
| RNAVGQDTQEVIVVP | 511 | P09619 | |
| LAVEQGAPVVVSAAV | 1221 | P98161 | |
| NATVEVDVQVPVSGL | 1791 | P98161 | |
| SVVVQPQASVGAVVT | 2896 | P98161 | |
| PAVRTVGALQVVQDT | 371 | Q9ULK6 | |
| QDVTVQAGVTPATIR | 491 | O15034 | |
| VQVQGVPVTITSVAG | 546 | Q02446 | |
| DGVKVQQATIAPVTV | 566 | Q02446 | |
| QQATIAPVTVAVGGI | 571 | Q02446 | |
| PVSVRVGQAVDVVGQ | 841 | Q13200 | |
| VDQVQDIVTGNPTVI | 951 | Q13576 | |
| AVQSIQQVVVTLGDP | 1341 | P57071 | |
| VVAVVPGLLEVTTQN | 1931 | Q6ZNJ1 | |
| EVVAVPTNGTVNNVA | 1451 | Q9Y520 | |
| GNIIPAIATTNAVIA | 381 | Q9UBT2 | |
| AIAVVPNVLANVGAA | 131 | Q9BR26 | |
| VVVGAPQEIVAANQR | 46 | P11215 | |
| SQIVALPEAQAFGVV | 196 | Q5PT55 | |
| VGEVSVLVNNAGVVS | 136 | Q8IZV5 | |
| VLAVSATAAAVVPEQ | 31 | Q9C0B6 | |
| AAAVQPAEVTVEVGE | 46 | A6NIR3 | |
| DTHQNVVVTEAGIIP | 201 | Q9H9P2 | |
| QQASVTAGKVPEVVA | 281 | Q15025 | |
| ATVPATAAGVVAVVV | 16 | Q9Y2T7 | |
| TGALAVAVAQPTDVV | 126 | P55851 | |
| VVQVTIPDGFVNVTV | 21 | Q86XK7 | |
| AEVTEVSVGANPVQV | 36 | P09486 | |
| GAVAAVQQEVPSAQS | 181 | P78364 | |
| QGVASVQVTPEAPAA | 241 | O95359 | |
| AGVAAPATQVAQVTL | 631 | Q15149 | |
| SITINVLGAAVVNQP | 621 | O43548 | |
| PQGVVVQPAAAVTTI | 2341 | Q9BYW2 | |
| VQPAAAVTTIVAPGQ | 2346 | Q9BYW2 | |
| AATAVTQLTVVPVGA | 671 | Q13105 | |
| TQLTVVPVGAAVTAD | 676 | Q13105 | |
| AQESPAAVEVLTQVV | 2046 | Q9C0G0 | |
| GVSQVAPAEPVAVAQ | 1041 | Q9H4A3 | |
| SGEELVVQVPVVDVQ | 26 | Q96GM8 | |
| TALQQAPAVDVVAIG | 251 | Q8NI36 | |
| NEVIETGPAVQVNAV | 3901 | Q5THJ4 | |
| EPVSVVAAVVDGAVV | 336 | Q86VE0 |